AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Apr 28 2022
News
Moderna asks FDA to authorize COVID vaccine for emergency use in children under 6
Moderna asked Food and Drug Administration (FDA) regulators on Thursday to authorize its COVID-19 vaccine for emergency use in children under 6 years of age.
The biotech company said the shot was about 51% effective against the virus for kids under 2 years old and about 37% effective in kids ages 2 to 5.
It added that similar requests are underway with international regulatory
Fox Business
Nov 19 2021
News
FDA authorizes Pfizer and Moderna Covid boosters for all US adults
US regulators on Friday opened up Covid-19 booster shots to all US adults, expanding the government’s campaign to shore up protection and get ahead of rising coronavirus cases that may worsen with the holidays.
Pfizer and Moderna announced the Food and Drug Administration’s (FDA) decision after at least 10 states already had started offering boosters to all adults.
The latest
The Guardian
Nov 12 2021
News
Regulator Reviewing Reports of ‘Rare’ and Serious Condition Linked to Moderna Vaccine
Europe’s drug regulator on Thursday confirmed it is investigating reports of a blood condition in recipients of Moderna’s mRNA COVID-19 vaccine.
According to a bulletin posted by the European Medicines Agency (EMA), it is reviewing six cases of capillary leak syndrome, considered a “very rare disorder,” after they were reported in the EMA’s EudraVigilance database.
“At this stage
The Epoch Times
Dec 18 2020
News
FDA grants emergency authorization to Moderna's Covid-19 vaccine
The Food and Drug Administration authorized Moderna's Covid-19 vaccine for emergency use Friday, adding a second vaccine to the country's arsenal to fight the pandemic.
The United States is the first country to greenlight use of Moderna's vaccine, which was developed in part with the National Institutes of Health.
The news was met with optimism. "I've never been more hopeful that
NBC News (Online)
Oct 20 2021
News
FDA OKs mixing COVID vaccines; backs Moderna, J&J boosters
U.S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially.
The Food and Drug Administration’s decisions mark a big step toward expanding the U.S. booster campaign, which began with extra doses of the
Associated Press
Dec 17 2020
News
Upstart Moderna takes on outsized role in U.S. vaccine effort
The nation’s second coronavirus vaccine, produced by Moderna, could be on its way to thousands of sites nationwide by this weekend — a major accomplishment for a company that has never before brought a product to market.
An independent Food and Drug Administration advisory committee on Thursday endorsed the shot for adults 18 and over, and the agency is expected to issue an emergency
Politico
Nov 09 2022
News
Moderna Shot May Cause Double To Triple As Many Heart Problems As Pfizer, New Study Finds
Moderna’s COVID-19 shot may cause two to three times as many heart-related side effects as Pfizer’s, according to a new Canadian study.
The rates of myocarditis and pericarditis in individuals within 21 days of getting their second shot were 35.6 and 22.9 per million doses, respectively, for Moderna compared to 12.6 and 9.4 per million for Pfizer, the research found. The connection
The Daily Caller
Dec 07 2020
News
Moderna, Pfizer Won't Attend White House Summit on Vaccines
The two pharmaceutical companies closest to gaining U.S. clearance for a Covid-19 vaccine won’t attend a planned White House summit intended to build confidence in the shots.
Pfizer Inc. said in a statement that it had informed the White House that it wouldn’t attend the Tuesday event. Moderna Inc. executives also won’t be present, according to a person familiar with the matter.
Newsmax (News)
Nov 16 2020
News
Moderna: Coronavirus vaccine nearly 95% effective in early look
Moderna’s coronavirus vaccine was nearly 95% effective and thwarted severe disease in an interim analysis, the company said Monday, putting a second drugmaker on track to request emergency approval before the end of the year.
The Cambridge, Massachusetts, company said it counted 95 cases within its trial of 30,000 participants. Only five of them were in the vaccine arm of the trial,
Washington Times
Sep 19 2020
News
Moderna President Shoots Down Media's Vaccine Fear-Mongering
In recent days, the liberal media have dedicated a lot of effort into stoking fear the coronavirus vaccines being developed by multiple pharmaceutical companies under the Trump administration’s Operation Warp Speed, which put the full weight of the U.S. government behind developing and distributing a safe and effective vaccine. Of course, they were taking their cues from the Biden campaign and
NewsBusters